GU CONNECT expert, Assoc. Prof. Martin Pichler provides a kidney cancer update from ASCO GU 2020 for you.


Kidney cancer update by Assoc. Prof. Martin Pichler, Medical University of Graz, Austria

 

Martin Pichler obtained his MD at the Medical University of Graz in 2006, and his Master of Science in Molecular Biology at the Karl-Franzens University of Graz, Austria. Martin continued his cancer research training in different places, including The UT MD Anderson Cancer Center, Houston, USA (where he is Adjunct Faculty member at the Department of Experimental Therapeutics). He currently works as a medical oncologist with special focus on Urogential- and Gastrointestinal cancer, at the Division of Oncology, Medical University of Graz, Austria. He currently holds the research managing director position of this division and is the Head of the Research Unit for Non-Coding RNAs and Genome Editing in Cancer. His main research focus is to study molecular mechanisms of cancer biology, prognostic biomarker studies and clinical trials. He received several awards, grants and published about 170 peer-reviewed papers so far (forschung.medunigraz.at).
Programme summary
Watch the video now
Other episodes of this series
GU CONNECT: Update from ASCO GU 2020

GU CONNECT: Update from ASCO GU 2020

Episode 1: Prostate Cancer
GU CONNECT Update from ASCO GU 2020

GU CONNECT Update from ASCO GU 2020

Episode 2: Urothelial Cancer
GU CONNECT Update from ASCO GU 2020

GU CONNECT Update from ASCO GU 2020

Episode 3: Kidney Cancer Current Episode
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GU CONNECT

GU CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer and Eisai Europe Limited.

Meet the experts Independent IME approved

Other programmes of interest

podcast Video podcast
Oncology 
Metastatic TNBC cannot wait

Optimising 1st line TROP2 ADC decisions in metastatic triple-negative breast cancer

Experts
Prof. Giuseppe Curigliano, Prof. Javier Cortés
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Oct 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from AstraZeneca.
conference-update Conference update

Episode

3

of 3

episode
Oncology 
How are new data shaping the landscape in HER2-mutant NSCLC?

Insights from WCLC 2026

Experts
Dr Joshua Sabari
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2026

Educational programme supported by an Independent Educational Grant from Bayer.